Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer
Clinical trial NCT01352884 · COMPLETED
Trial details
- NCT number
- NCT01352884
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-11-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.